A long-term study of the Framingham Heart Study Offspring cohort found that low-carbohydrate diets emphasizing high-quality ...

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Tourmaline Bio, Inc. (NASDAQ:TRML) while keeping the price target ...

Researchers at ETH Zurich have developed the first technology that is able to recognize biomarkers in menstrual ...

Inflammatory foods include red meat, processed foods, refined carbohydrates, fried food, and sugary drinks. They can cause ...

Glyceraldehyde links chronic stress to depression by driving inflammation and telomere shortening, offering a potential ...

Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and cardiovascular pathology.

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers ...

Tourmaline Bio is well-funded, with cash runway into 2H 2027, minimizing near-term dilution risk for investors. Click here to ...

Residual inflammation persisted among patients with psoriasis despite optimal disease response to biologic therapies, putting ...

Tourmaline Bio (TRML) stock falls as the company posts mid-stage initial trial for lead asset pacibekitug in kidney disease patients with high CRP. Read more here.

Pacibekitug, an antibody targeting interleukin-6, hit the primary endpoint in the phase 2 Tranquility trial by sharply ...